217 related articles for article (PubMed ID: 9032258)
1. Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding.
Parra E; Varga M; Hedlund G; Kalland T; Dohlsten M
Mol Cell Biol; 1997 Mar; 17(3):1314-23. PubMed ID: 9032258
[TBL] [Abstract][Full Text] [Related]
2. Costimulation of human CD4+ T cells with LFA-3 and B7 induce distinct effects on AP-1 and NF-kappa B transcription factors.
Parra E; Varga M; Sigvardsson M; Hedlund G; Kalland T; Leanderson T; Sjögren HO; Dohlsten M
J Immunol; 1995 Aug; 155(3):1132-40. PubMed ID: 7543515
[TBL] [Abstract][Full Text] [Related]
3. Identification of a CD28 response element in the CD40 ligand promoter.
Parra E; Mustelin T; Dohlsten M; Mercola D
J Immunol; 2001 Feb; 166(4):2437-43. PubMed ID: 11160303
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
Parra E; McGuire K; Hedlund G; Dohlsten M
J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
[TBL] [Abstract][Full Text] [Related]
5. The MAP kinases are differently utilized by CD28 and CD2 adhesion pathways in superantigen-activated Jurkat T cells.
Visse E; Inostroza J; Cabello G; Parra E
Biol Res; 2003; 36(2):263-78. PubMed ID: 14513721
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.
Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H
J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538
[TBL] [Abstract][Full Text] [Related]
7. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles.
Wingren AG; Parra E; Varga M; Kalland T; Sjögren HO; Hedlund G; Dohlsten M
Crit Rev Immunol; 1995; 15(3-4):235-53. PubMed ID: 8834450
[TBL] [Abstract][Full Text] [Related]
8. Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2.
Lindgren H; Axcrona K; Leanderson T
J Immunol; 2001 Apr; 166(7):4578-85. PubMed ID: 11254715
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
McGuire KL; Iacobelli M
J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors.
Maggirwar SB; Harhaj EW; Sun SC
Mol Cell Biol; 1997 May; 17(5):2605-14. PubMed ID: 9111330
[TBL] [Abstract][Full Text] [Related]
11. Costimulation of human CD4+ T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles.
Parra E; Wingren AG; Hedlund G; Björklund M; Sjögren HO; Kalland T; Sansom D; Dohlsten M
J Immunol; 1994 Sep; 153(6):2479-87. PubMed ID: 7521363
[TBL] [Abstract][Full Text] [Related]
12. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
[TBL] [Abstract][Full Text] [Related]
13. CD28 and LFA-1 contribute to cyclosporin A-resistant T cell growth by stabilizing the IL-2 mRNA through distinct signaling pathways.
Geginat J; Clissi B; Moro M; Dellabona P; Bender JR; Pardi R
Eur J Immunol; 2000 Apr; 30(4):1136-44. PubMed ID: 10760803
[TBL] [Abstract][Full Text] [Related]
14. CD28 signaling augments Elk-1-dependent transcription at the c-fos gene during antigen stimulation.
Li W; Whaley CD; Bonnevier JL; Mondino A; Martin ME; Aagaard-Tillery KM; Mueller DL
J Immunol; 2001 Jul; 167(2):827-35. PubMed ID: 11441089
[TBL] [Abstract][Full Text] [Related]
15. Functional disparity of distinct CD28 response elements toward mitogenic responses.
Civil A; Rensink I; Aarden LA; Verweij CL
J Biol Chem; 1999 Nov; 274(48):34369-74. PubMed ID: 10567414
[TBL] [Abstract][Full Text] [Related]
16. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB.
Kalli K; Huntoon C; Bell M; McKean DJ
Mol Cell Biol; 1998 Jun; 18(6):3140-8. PubMed ID: 9584155
[TBL] [Abstract][Full Text] [Related]
17. The role of B7-1 and LFA-3 in costimulation of CD8+ T cells.
Parra E; Wingren AG; Hedlund G; Kalland T; Dohlsten M
J Immunol; 1997 Jan; 158(2):637-42. PubMed ID: 8992978
[TBL] [Abstract][Full Text] [Related]
18. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28.
Slavik JM; Hutchcroft JE; Bierer BE
J Biol Chem; 1999 Jan; 274(5):3116-24. PubMed ID: 9915850
[TBL] [Abstract][Full Text] [Related]
19. Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.
Good L; Maggirwar SB; Sun SC
EMBO J; 1996 Jul; 15(14):3744-50. PubMed ID: 8670878
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.
Gringhuis SI; de Leij LF; Verschuren EW; Borger P; Vellenga E
Blood; 1997 Oct; 90(7):2690-700. PubMed ID: 9326236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
